Clinical Trial Update: Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy of dalfampridine on upper extremity function in patients with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Multiple Sclerosis | Phase 4 | Status: UNKNOWN